RyR2 is predominantly expressed in both the heart and the brain, and this could be the reason why the mutation of RyR2 could have various clinical manifestations of different severity, of which CPVT is only the most dangerous. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.